Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report
Int. Journal of Clinical Pharmacology and Therapeutics · 01.02.2026 · 64 (02) · 92-96
DOI: 10.5414/cp204660 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.02.2026. Verfasst von Nouha Trad und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Hepatitis, Autoimmune, Immunosuppressive Agents, Mycophenolic Acid.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Trad, N., Mensi, A., BelHadj Mabrouk, E., Zaimi, Y., Ayadi, S., Mouelhi, L., Said, Y., & Dabbeche, R. (2026). Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report. Int. Journal of Clinical Pharmacology and Therapeutics, 64(02), 92-96. https://doi.org/10.5414/cp204660
Vancouver
Trad N, Mensi A, BelHadj Mabrouk E, Zaimi Y, Ayadi S, Mouelhi L, et al. Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(02):92-96. doi:10.5414/cp204660
BibTeX
@article{Trad2026,
author = {Trad, Nouha and Mensi, Asma and BelHadj Mabrouk, Emna and Zaimi, Yosra and Ayadi, Shema and Mouelhi, Leila and Said, Yosra and Dabbeche, Radhouene},
title = {Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {02},
pages = {92--96},
doi = {10.5414/cp204660}
}
EUVIMED